Global vaccine output remains highly concentrated among a few major producers. Here’s a snapshot of the latest estimates: (Note: Many companies do not publish per‑vaccine production figures; numbers marked with “~” are...
Europe kicked off 2026 by adding more brains to the vaccine bureaucracy, designating a new WHO Collaborating Centre to help NITAGs turn messy evidence into cleaner policy decisions. In theory, this means fewer hand‑wavy...
In the wake of the COVID19 pandemic and the evolution of mRNA vaccines, the global vaccine industry in 2025 is characterized by rapid expansion of manufacturing capacity, especially for mRNA and other novel platforms...
1. Pfizer (USA) and BioNTech (Germany) News: Pfizer and BioNTech have submitted a new application to the European Medicines Agency for a COVID-19 vaccine adapted to the 2025–2026 LP.8.1 strain. Pfizer and BioNTech...